ReviewPLoS neglected tropical diseases2009
The global burden of trachoma: a review.
Review in PLoS neglected tropical diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
119 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Pooled it
- Prevalence and associated factors of active trachoma among children of 1 to 9 years in low-income countries of Africa: a systematic review and meta-analysis.Frontiers in public health · 2025Pooled it
- Pooled it
- Prevalence and associated factors of active trachoma among children in Ethiopia: a systematic review and meta-analysis.BMC infectious diseases · 2019Pooled it
- Antibiotics for trachoma.The Cochrane database of systematic reviews · 2019Pooled it
- Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis.PLoS medicine · 2014Pooled it
- Epidemiology and control of trachoma: systematic review.Tropical medicine & international health : TM & IH · 2010Pooled it
- Benefits and Costs of a Community-Led Total Sanitation Intervention in Rural Ethiopia-A Trial-Based ex post Economic Evaluation.International journal of environmental research and public health · 2020Trial
- Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment.PloS one · 2019Trial
- Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.Ophthalmic epidemiology · 2016Trial
- A randomised controlled trial to investigate effects of enhanced supervision on primary eye care services at health centres in Kenya, Malawi and Tanzania.BMC health services research · 2014Trial
- Pathogenicity and virulence ofVirulence · 2025Review
- Assessing the effectiveness of the community participation approaches to improve access to mass drug administration for trachoma elimination in a pastoral conflict area of Baringo County, Kenya.PLoS neglected tropical diseases · 2025Article
- Trachoma.Lancet (London, England) · 2025Review
- NQR as a target for new antibiotics.Frontiers in microbiology · 2025Review
- Infectious eye disease in the 21st century-an overview.Eye (London, England) · 2024Review
- Challenges in Chlamydial Serology: Insights from a Belgian and a Dutch Population Cohort.Microorganisms · 2024Article
- Prevalence of trachomatous inflammation-follicular and associated factors among children aged 1-9 years in northeastern Ethiopia.BMC pediatrics · 2024Article
- Knowledge, Practice and Associated Factor of Trachoma Transmission and Prevention Among Primary School Students in Addis Zemen Town, South Gondar, Northwest Ethiopia.Environmental health insights · 2024Article
- Modelling morbidity for neglected tropical diseases: the long and winding road from cumulative exposure to long-term pathology.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023Review
59 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Trachoma is the commonest infectious cause of blindness worldwide. Recurrent infection of the ocular surface by Chlamydia trachomatis, the causative agent, leads to inturning of the eyelashes (trichiasis) and blinding corneal opacification. Trachoma is endemic in more than 50 countries. It is currently estimated that there are about 1.3 million people blind from the disease and a further 8.2 million have trichiasis. Several estimates for the burden of disease from trachoma have been made, giving quite variable results. The variation is partly because different prevalence data have been used and partly because different sequelae have been included. The most recent estimate from the WHO placed it at around 1.3 million Disability-Adjusted Life Years (DALYs). A key issue in producing a reliable estimate of the global burden of trachoma is the limited amount of reliable survey data from endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.